24小时热门版块排行榜    

查看: 145  |  回复: 0
当前主题已经存档。

abcd888898

银虫 (正式写手)

[交流] 【转帖】Roche provides update on phase III study of Avastin

Roche provides update on phase III study of Avastin in men with late stage prostate cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the topline results of a phase III trial led by the US Cancer and Leukemia Group B (CALGB) and sponsored by the National Cancer Institute investigating the use of Avastin (bevacizumab) in combination with docetaxel chemotherapy and prednisone in men with late stage prostate cancer (hormone-refractory / HRPC). The study, known as CALGB 90401, did not meet its primary objective of extending overall survival compared to chemotherapy and prednisone alone. A preliminary assessment of safety performed by CALGB has shown adverse events that have been previously observed in pivotal trials with Avastin. Data from the study will be submitted by CALGB for presentation at the 2010 American Society of Clinical Oncology (ASCO) annual meeting, June 4 to 8, 2010.

“Patients with hormone-refractory prostate cancer are in urgent need of new treatment options. It is unfortunate that the study did not meet its primary objective, however, we look forward to sharing the data with the medical community, including the secondary endpoints,” said Hal Barron, M.D., Head Global Development and Chief Medical Officer at Roche.

These findings do not impact Avastin’s approved indications, where Avastin has made anti-angiogenic therapy a fundamental pillar of cancer treatment. Avastin’s broad development programme in other tumour types will also continue as planned.
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 abcd888898 的主题更新
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[基金申请] 生生命学部会评 +3 wuke100666 2026-07-15 3/150 2026-07-15 17:11 by kingkocxr
[基金申请] E口青C会评结束了吗? 40+3 小小书虫c 2026-07-14 9/450 2026-07-15 16:04 by 安静的知了
[基金申请] 会评 +3 无名者登山 2026-07-15 3/150 2026-07-15 14:45 by Vivilian
[基金申请] 生命口C13面上会评时间 +6 luckinging 2026-07-14 9/450 2026-07-15 14:39 by 雨冰共舞
[教师之家] 内心匮乏 +13 水冰月月野兔 2026-07-12 13/650 2026-07-15 14:21 by jiduquegai
[文学芳草园] 你可曾有过这种感受? +3 Jeanya 2026-07-09 6/300 2026-07-15 11:07 by mbtwt
[论文投稿] 农业机械学报投稿周期 +3 G0DLIN 2026-07-14 7/350 2026-07-15 09:26 by xs74101122
[基金申请] 国自然面上D口祈祷 +4 monkeynana 2026-07-14 4/200 2026-07-15 09:14 by 白水煮
[论文投稿] 跨出版社商投稿 20+4 倪好520 2026-07-13 4/200 2026-07-15 08:35 by bobvan
[基金申请] 没收到消息,再次陪跑 +3 天空星辰fly 2026-07-14 3/150 2026-07-14 19:14 by 6543yes
[基金申请] 不要再数国自然申请书的 filecode 的分隔符个数了 +13 sadpencil 2026-07-12 20/1000 2026-07-14 13:12 by 杠就是你对
[基金申请] 明天E口面上会评 +8 布布和一二 2026-07-12 9/450 2026-07-13 22:59 by QTSorange
[论文投稿] MSER送审了还被拒稿 +4 S778950906 2026-07-08 6/300 2026-07-13 16:22 by tfang
[基金申请] 祈祷青基必中 50+6 hadengry 2026-07-09 16/800 2026-07-12 20:31 by 登山虫虫
[考博] 27届辽宁大学应届毕业生申博 +3 可乐微风大海 2026-07-09 3/150 2026-07-10 21:23 by 贪玩的研究僧
[基金申请] 关于如何从代码看上不上会 +17 且听虎啸 2026-07-09 23/1150 2026-07-10 19:51 by sdfapple719
[有机交流] chemdraw 20+5 ?慕鱼? 2026-07-08 6/300 2026-07-10 15:37 by 紫枫星域
[基金申请] b口会评 +6 当空照 2026-07-08 6/300 2026-07-09 20:49 by tonyliu0401
[考研] 在职考研 +6 wu5d 2026-07-08 7/350 2026-07-09 16:40 by 化工小霸王呀
[基金申请] 化学口会评?应用基础研究和基础研究,希望能分开 +3 Tide man 2026-07-08 3/150 2026-07-09 11:36 by dede5556
信息提示
请填处理意见